Glazer Capital LLC’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,254,733
| Closed | -$12.7M | – | 517 |
|
|
2022
Q4 | $12.7M | Buy |
1,254,733
+259,259
| +26% | +$2.62M | 0.33% | 106 |
|
|
2022
Q3 | $9.86M | Buy |
995,474
+287,251
| +41% | +$2.84M | 0.18% | 174 |
|
|
2022
Q2 | $6.93M | Buy |
708,223
+523,267
| +283% | +$5.12M | 0.17% | 188 |
|
|
2022
Q1 | $1.8M | Buy |
184,956
+183,013
| +9,419% | +$1.78M | 0.05% | 262 |
|
|
2021
Q4 | $19K | Hold |
1,943
| – | – | ﹤0.01% | 776 |
|
|
2021
Q3 | $19K | Buy |
1,943
+1,906
| +5,151% | +$18.6K | ﹤0.01% | 864 |
|
|
2021
Q2 | $0 | Buy |
+37
| New | – | ﹤0.01% | 985 |
|